HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Drug Pipeline
RCT
Zastaprazan 20 mg noninferior to lansoprazole 30 mg for gastric ulcer healing at 8 weeks
New medication shows promise for healing gastric ulcers
This Phase 3 randomized, double-blind, active-controlled trial of 329 patients with confirmed gastric ulcers found zastaprazan 20 mg once da…
A new medication called zastaprazan showed a high healing rate for gastric ulcers, performing similarly to the current standard treatment.
Sep 19, 2026
Rheumatology
Meta-analysis
Vonoprazan reduces delayed bleeding risk in patients with gastric post-endoscopic submucosal dissection ulcers
Vonoprazan may reduce bleeding risk for patients with gastric ulcers
This meta-analysis of 1,136 patients found that vonoprazan significantly reduced the risk of delayed bleeding compared to proton pump inhibi…
A new medication called vonoprazan may lower the risk of bleeding for patients with gastric ulcers compared to standard acid-blocking treatm…
Frontiers
Sep 11, 2026